• 2012

Company Description

Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment

Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2012
  • Founders:

    Phil Reaston
  • Company Website:

  • Company E-mail:

  • Company Address:

    5924 Balfour Ct., Suite 102
    Carlsbad, CA
    United States
  • CEO:

    • Phil Reaston
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits